Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Sells 850 Shares of Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Jill Anderson sold 850 shares of Merit Medical Systems stock in a transaction that occurred on Friday, September 10th. The stock was sold at an average price of $71.64, for a total transaction of $60,894.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Shares of NASDAQ:MMSI opened at $71.55 on Wednesday. The firm has a fifty day moving average of $67.17 and a two-hundred day moving average of $63.01. The firm has a market capitalization of $4.03 billion, a P/E ratio of 143.10, a price-to-earnings-growth ratio of 2.47 and a beta of 1.25. Merit Medical Systems, Inc. has a 12-month low of $39.44 and a 12-month high of $73.85. The company has a quick ratio of 1.21, a current ratio of 2.14 and a debt-to-equity ratio of 0.29.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, July 29th. The medical instruments supplier reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.44 by $0.18. Merit Medical Systems had a net margin of 2.74% and a return on equity of 12.42%. Equities research analysts expect that Merit Medical Systems, Inc. will post 2.14 earnings per share for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. lifted its stake in shares of Merit Medical Systems by 2.8% in the 1st quarter. BlackRock Inc. now owns 7,822,133 shares of the medical instruments supplier’s stock valued at $468,389,000 after purchasing an additional 212,022 shares during the last quarter. William Blair Investment Management LLC lifted its stake in shares of Merit Medical Systems by 2.6% in the 1st quarter. William Blair Investment Management LLC now owns 3,476,929 shares of the medical instruments supplier’s stock valued at $208,199,000 after purchasing an additional 89,564 shares during the last quarter. Conestoga Capital Advisors LLC lifted its stake in shares of Merit Medical Systems by 1.0% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 2,354,467 shares of the medical instruments supplier’s stock valued at $152,240,000 after purchasing an additional 23,030 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Merit Medical Systems by 5.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,661,794 shares of the medical instruments supplier’s stock valued at $107,451,000 after purchasing an additional 88,635 shares during the last quarter. Finally, Macquarie Group Ltd. lifted its stake in shares of Merit Medical Systems by 1.9% in the 2nd quarter. Macquarie Group Ltd. now owns 1,424,983 shares of the medical instruments supplier’s stock valued at $92,140,000 after purchasing an additional 26,057 shares during the last quarter. 94.47% of the stock is owned by institutional investors and hedge funds.

Several equities analysts have weighed in on MMSI shares. Barrington Research lifted their price objective on shares of Merit Medical Systems from $71.00 to $79.00 and gave the stock an “outperform” rating in a research report on Friday, July 30th. Piper Sandler lifted their price objective on shares of Merit Medical Systems from $73.00 to $79.00 and gave the stock an “overweight” rating in a research report on Friday, July 30th. Raymond James lifted their price objective on shares of Merit Medical Systems from $69.00 to $73.00 and gave the stock an “outperform” rating in a research report on Friday, July 30th. Needham & Company LLC lifted their price objective on shares of Merit Medical Systems from $73.00 to $83.00 and gave the stock a “buy” rating in a research report on Friday, July 30th. Finally, Wells Fargo & Company lifted their price objective on shares of Merit Medical Systems from $65.00 to $68.00 and gave the stock an “equal weight” rating in a research report on Friday, July 30th. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $71.56.

About Merit Medical Systems

Merit Medical Systems, Inc engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups.

Further Reading: What does a hold rating mean?

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.